DCF Advisers’s Corvus Pharmaceuticals CRVS Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2025
Q2
$3.03M Buy
757,500
+357,500
+89% +$1.43M 1.4% 27
2025
Q1
$1.27M Buy
+400,000
New +$1.27M 0.61% 43